Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.41 |
| ▸ | PRMT1 | Q99873 | 3/20 | 0.40 |
| ▸ | FOLR1 | P15328 | 6/20 | 0.38 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.36 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 3/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 3/20 | 0.36 |
| ▸ | TLR2 | O60603 | 1/20 | 0.36 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.36 |
| ▸ | CARM1 | Q86X55 | 1/20 | 0.36 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.36 |
| ▸ | HRH2 | P25021 | 2/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4753231 | 0.94 | HTR1A (0.44) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753483 | 0.94 | HTR1A (0.41) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753382 | 0.94 | HTR1A (0.41) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753489 | 0.93 | HTR1A (0.41) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753456 | 0.93 | HTR1A (0.41) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753488 | 0.91 | PRMT1 (0.40) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL13100833 | 0.90 | HTR1A (0.42) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753389 | 0.89 | HTR1A (0.44) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL4753486 | 0.87 | HTR1A (0.41) | HTR1APRMT1FOLR1CHRM2CHRM4 | |
| SCHEMBL13100832 | 0.87 | PRMT1 (0.42) | HTR1APRMT1FOLR1CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8313885-B2 | Lithographic printing plate precursor comprising bi-functional compounds | AGFA GRAPHICS NV (BE) | 2012-11-20 | — | — | US | disclosed |
| US-8178282-B2 | Heat-sensitive imaging element | AGFA GRAPHICS NV (BE) | 2012-05-15 | — | — | US | disclosed |
| US-20100274023-A1 | NOVEL INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF MESO-SUBSTITUTED CYANINE, MEROCYANINE AND OXONOLE DYES | AGFA GRAPHICS NV (BE) | 2010-10-28 | — | — | US | disclosed |
| US-20100040976-A1 | HEAT-SENSITIVE IMAGING ELEMENT | AGFA GRAPHICS NV (BE) | 2010-02-18 | — | — | US | disclosed |
| US-20070105041-A1 | Lithographic printing plate comprising bi-functional compounds | AGFA-GEVAERT (BE) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100040976-A1 | HEAT-SENSITIVE IMAGING ELEMENT | HEATR1, HEATR6, HSPA8 | HTR1A 1158/4885PRMT1 4821/4885FOLR1 4305/4885 |
| US-20100274023-A1 | NOVEL INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF MESO-SUBSTITUTED CYANINE, MEROCYANINE AND OXONOLE DYES | MB, MYADM, PYCR1 | HTR1A 3200/4885PRMT1 418/4885FOLR1 1612/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.